Amberjack Capital Partners, L.P. filed a Form 13F-HR with the Securities and Exchange Commission on November 2, 2026, disclosing its equity securities portfolio as of September 30, 2026. The filing indicates that the firm holds a single position in Innovex International Inc.
According to the information table provided in the filing, Amberjack Capital Partners holds 47,980,284 shares of Innovex International Inc. common stock. The total value of this holding is reported as $17,757,322.
The filing identifies Innovex International Inc. as the sole issuer in the portfolio, with the position held as a sole voting power and sole dispositive power. The filing was signed by John Christopher Trampe, the Chief Compliance Officer for Amberjack Capital Partners.